Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Enzo Biochem, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $31.91M | $31.06M | $107.07M | $117.73M | $76.02M | $81.17M | $104.71M | $107.80M | $102.77M | $97.60M |
| Revenue Growth? | +2.7% | -71.0% | -9.1% | +54.9% | -6.3% | -22.5% | -2.9% | +4.9% | +5.3% | 0.0% |
| Cost of Revenue? | $17.27M | $19.50M | $65.10M | $64.15M | $52.25M | $57.92M | $60.38M | $59.48M | $57.19M | $54.77M |
| Gross Profit? | $14.63M | $11.57M | $41.97M | $53.58M | $23.77M | $23.25M | $44.33M | $48.33M | $45.58M | $42.83M |
| Gross Margin? | +45.9% | +37.2% | +39.2% | +45.5% | +31.3% | +28.6% | +42.3% | +44.8% | +44.4% | +43.9% |
| Operating Expenses? | $24.36M | $31.11M | $57.47M | $48.16M | $47.41M | $47.44M | $51.37M | $49.71M | $49.45M | $46.70M |
| Operating Income? | -$9.82M | -$24.74M | -$15.51M | $9.88M | -$23.64M | $78.13M | -$12.16M | -$3.07M | $47.00M | -$1.21M |
| EBITDA? | -$8.35M | -$22.34M | -$15.01M | $3.35M | -$27.59M | -$24.16M | -$3.91M | $1.09M | -$6.56M | -$1.21M |
| Income Before Tax | -$9.82M | -$25.02M | -$18.26M | $7.88M | -$28.52M | $2.49M | -$11.42M | -$2.42M | $46.52M | -$2.29M |
| Income Tax Expense | $0 | $0 | $4.32M | $0 | $0 | $101.27M | -$1.10M | $82,000 | $1.23M | -$7,000 |
| Net Income? | -$26.08M | $20.29M | -$22.58M | $3.42M | -$33.89M | -$98.78M | -$10.32M | -$2.50M | $45.29M | -$2.29M |
| EPS? | $-0.51 | $-1.27 | $-0.46 | $0.07 | $-0.71 | $-2.09 | $-0.22 | $-0.05 | $0.98 | $-0.05 |
| Diluted EPS? | $-0.51 | $-1.27 | $-0.46 | $0.07 | $-0.71 | $-2.08 | $-0.22 | $-0.05 | $0.97 | $-0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality